tiprankstipranks
Immutep (IMMP)
NASDAQ:IMMP
US Market

Immutep (IMMP) Stock Forecast & Price Target

Compare
653 Followers
See the Price Targets and Ratings of:

IMMP Financial Forecast

IMMP Earnings Forecast

Next quarter’s earnings estimate for IMMP is -$0.13 with a range of -$0.13 to -$0.13. The previous quarter’s EPS was -$0.10. IMMP beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.33% of the time in the same period. In the last calendar year IMMP has Outperformed its overall industry.
Next quarter’s earnings estimate for IMMP is -$0.13 with a range of -$0.13 to -$0.13. The previous quarter’s EPS was -$0.10. IMMP beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.33% of the time in the same period. In the last calendar year IMMP has Outperformed its overall industry.

IMMP Sales Forecast

Next quarter’s sales forecast for IMMP is $1.97M with a range of $1.97M to $1.97M. The previous quarter’s sales results were $0.00. IMMP beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 46.78% of the time in the same period. In the last calendar year IMMP has Preformed in-line its overall industry.
Next quarter’s sales forecast for IMMP is $1.97M with a range of $1.97M to $1.97M. The previous quarter’s sales results were $0.00. IMMP beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 46.78% of the time in the same period. In the last calendar year IMMP has Preformed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Maxim Group
$12
Buy
552.17%
Upside
Reiterated
12/12/24
Immutep's Eftilagimod Alpha Shows Promising Results in Head and Neck Cancer Study, Justifying Buy Rating
Robert W. Baird
$7
Buy
280.43%
Upside
Assigned
11/14/24
Immutep price target raised to $7 from $6 at BairdImmutep price target raised to $7 from $6 at Baird
Capital One Financial
$8
Buy
334.78%
Upside
Reiterated
09/19/24
Buy Rating Affirmed for Immutep on Promising Efti Outlook Despite Mixed Study Interpretations
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Maxim Group
$12
Buy
552.17%
Upside
Reiterated
12/12/24
Immutep's Eftilagimod Alpha Shows Promising Results in Head and Neck Cancer Study, Justifying Buy Rating
Robert W. Baird
$7
Buy
280.43%
Upside
Assigned
11/14/24
Immutep price target raised to $7 from $6 at BairdImmutep price target raised to $7 from $6 at Baird
Capital One Financial
$8
Buy
334.78%
Upside
Reiterated
09/19/24
Buy Rating Affirmed for Immutep on Promising Efti Outlook Despite Mixed Study Interpretations
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

IMMP Analyst Recommendation Trends

Rating
Jul 24
Sep 24
Oct 24
Nov 24
Dec 24
Strong Buy
10
12
9
7
4
Buy
1
1
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
11
13
9
7
4
In the current month, IMMP has received 4 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. IMMP average Analyst price target in the past 3 months is $12.00.
Each month's total comprises the sum of three months' worth of ratings.

IMMP Stock Forecast FAQ

What is IMMP’s average 12-month price target, according to analysts?
Based on analyst ratings, Immutep’s 12-month average price target is $12.00.
    What is IMMP’s upside potential, based on the analysts’ average price target?
    Immutep has 552.17% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is IMMP a Buy, Sell or Hold?
          Immutep has a consensus rating of Moderate Buy which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Immutep’s price target?
            The average price target for Immutep is $12.00. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $12.00 ,the lowest forecast is $12.00. The average price target represents 552.17% Increase from the current price of $1.84.
              What do analysts say about Immutep?
              Immutep’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 0 Wall Streets Analysts.
                How can I buy shares of IMMP?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis